| # | Drug | Count |
|---|---|---|
| 0 | ORAL SEMAGLUTIDE | 582 |
| 1 | LIRAGLUTIDE | 478 |
| 2 | LEVOTHYROXINE SODIUM | 236 |
| 3 | ORFORGLIPRON | 218 |
| 4 | LEVONORGESTREL | 135 |
| 5 | TIRZEPATIDE | 108 |
| 6 | PREDNISONE | 101 |
| 7 | ASPIRIN | 100 |
| 8 | ADALIMUMAB | 98 |
| 9 | ASPIRIN 325 MG | 97 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ORFORGLIPRON | 218 | 0.0713 |
| 1 | SETMELANOTIDE | 16 | 0.0561 |
| 2 | BEXAGLIFLOZIN | 1 | 0.0323 |
| 3 | NIACINAMIDE, ZINC GLYCINATE, LEVOMEFOLATE CALCIUM, CUPRIC OXIDE, SELENIUM AND CHROMIUM | 1 | 0.0278 |
| 4 | LEVOKETOCONAZOLE | 8 | 0.0106 |
| 5 | LIRAGLUTIDE | 478 | 0.0096 |
| 6 | ISOPROTERENOL HYDROCHLORIDE | 4 | 0.0092 |
| 7 | ERTUGLIFLOZIN AND SITAGLIPTIN | 1 | 0.0083 |
| 8 | CLOMIPHENE CITRATE | 12 | 0.0080 |
| 9 | ORAL SEMAGLUTIDE | 582 | 0.0075 |
| # | Drug class | Count |
|---|---|---|
| 0 | GLP-1 Receptor Agonist [EPC] | 1197 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 208 |
| 2 | Corticosteroid [EPC] | 167 |
| 3 | Progestin [EPC] | 163 |
| 4 | Angiotensin 2 Receptor Blocker [EPC] | 154 |
| 5 | Progestin-containing Intrauterine System [EPC] | 135 |
| 6 | Benzodiazepine [EPC] | 123 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 111 |
| 8 | Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] | 108 |
| 9 | Proton Pump Inhibitor [EPC] | 106 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Melanocortin 4 Receptor Agonist [EPC] | 16 | 0.0561 |
| 1 | Cortisol Synthesis Inhibitor [EPC] | 8 | 0.0106 |
| 2 | Interleukin-5 Antagonist [EPC] | 4 | 0.0058 |
| 3 | Guanylate Cyclase-C Agonist [EPC] | 9 | 0.0043 |
| 4 | Provitamin D2 Compound [EPC] | 97 | 0.0033 |
| 5 | GLP-1 Receptor Agonist [EPC] | 1197 | 0.0027 |
| 6 | Adrenocorticotropic Hormone [EPC] | 2 | 0.0022 |
| 7 | CCR5 Co-receptor Antagonist [EPC] | 5 | 0.0022 |
| 8 | Progestin Antagonist [EPC] | 8 | 0.0017 |
| 9 | Non-Standardized Pollen Allergenic Extract [EPC] | 1 | 0.0016 |